| Literature DB >> 32506786 |
Renzi Andrea1, Morandi Luca2, Lenzi Jacopo3, Rigillo Antonella1, Bettini Giuliano1, Bellei Emma1, Giacomini Alessandra1, Tinto Debora1, Sabattini Silvia1.
Abstract
Feline oral squamous cell carcinoma (FOSCC) is characterized by high local invasiveness and early bone lysis. The late diagnosis largely limits the efficacy of therapy and increases treatment-related morbidity. The aim of this exploratory study was to assess the methylation pattern of 10 candidate genes and TP53 mutational status in histologic samples of FOSCC. Results were compared with normal oral mucosa and oral inflammatory lesions, in order to establish a gene panel for FOSCC detection. For 10 cats, the above analyses were also performed on oral brushing samples, in order to explore the utility of these methods for screening purposes. Thirty-one FOSCC, 25 chronic inflammatory lesions and 12 controls were included. TP53 mutations were significantly more frequent in FOSCC (68%) than in non-neoplastic oral mucosa (3%; P < 0.001) Based on lasso regression analysis, a step-wise algorithm including TP53, FLI1, MiR124-1, KIF1A and MAGEC2 was proposed. The algorithm allowed to differentiate FOSCC with a 94% sensitivity and 100% specificity (accuracy, 97%). When applying the proposed algorithm on brushing samples, accuracy decreased to 80%. These results indicate that altered DNA methylation of specific promoter genes are present in FOSCC, together with a significant proportion of TP53 mutations. Such alterations are infrequent in normal oral mucosa and chronic stomatitis in cats, suggesting their involvement in feline oral carcinogenesis and their utility as diagnostic biomarkers. Further studies on a high number of brushing samples will be needed to assess the utility of a screening test for the early detection of FOSCC. This article is protected by copyright. All rights reserved.Entities:
Keywords: DNA methylation; bisulfite next generation sequencing; diagnosis; feline; oral; p53; squamous cell carcinoma
Year: 2020 PMID: 32506786 DOI: 10.1111/vco.12624
Source DB: PubMed Journal: Vet Comp Oncol ISSN: 1476-5810 Impact factor: 2.613